Skip to content
Home/Companies/MedTech/Bomi Group

Bomi Group

MedTech·Italy·Exited 2023·Held 4yr
Entry
2019
Hold
4yr
Exit
2023

Who owns Bomi Group?

Bomi Group was owned by ARCHIMED through MED Platform I (2019 vintage) from 2019 to 2023, exited via Trade Sale.

Buyer identity and MOIC available on Pro.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED Platform I · 2019 · Buyout

Key facts

HQItaly
SectorMedTech
Exit Type
Trade Sale
Buyer
MOIC
Exit Year
2023

More from MED Platform I

Other portfolio companies in the same fund.

CARSO
Carso
Active
MedTechFrance· 2021
Ad-Tech Medical Instrument
Exited 2024
MedTechUS· 2020
to
Ametris (ActiGraph)
Ametris (ActiGraph)
Exited 2026
HealthTechUS· 2020
to
Namsa
Active
MedTechUS· 2020
ZYTOMICS
Zytomics
Active
MedTechGermany· 2020
Direct Healthcare Group
Exited 2026
MedTechUK· 2019
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Clee Medical
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)Switzerland· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Track Bomi Group

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Bomi Group.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue